Thursday, November 7, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com ...

To Dioselina Salto, the first two weeks of motherhood were amazing, even though she spent much of it in the hospital after her daughter was born prematurely. She visited her daughter Janelle twice a ...

As its biggest competitor in the CGM market, Abbott Laboratories, pointed out ... And DexCom is building a network effect ...

In addition to the above companies, the ones that will be declaring their Q2 results on Nov. 7 include NHPC, Aditya Birla Fashion and Retail, Bajaj Electricals and Cummins India.

Today's long list of companies posting Q2 results includes fashion retailer Aditya Birla Fashion and Retail, BEML land assets, diesel and gas engine manufacturer Cummins India, agri machinery ...

Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other pharma stocks. Healthcare takes the concept of 'defensive' further than almost any ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Following the robust Q3 performance, Piper Sandler raised ABT’s price target to $133 from $131, keeping an Overweight rating ...